CTOs on the Move

Tapinator

www.tapinator.com

 
Tapinator (Ticker: TAPM) is a global developer and publisher of mobile games on the iOS, Google Play, and Amazon platforms. The Company focuses on operating its own titles, publishing properties where it holds substantial ownership positions, and making strategic investments into promising mobile companies. Tapinator’s owned and operated portfolio includes over 55 mobile gaming titles that, collectively, have over 30 million users. A number of these titles have risen to the top of the mobile leaderboard charts and have been featured by the Apple, Google, and Amazon App Stores. Founded in 2013, Tapinator is headquartered in New York, with development ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tapinator.com
  • 140 West 57th Street; Suite 9C
    New York, NY USA 10019
  • Phone: 914.930.6232

Executives

Name Title Contact Details

Similar Companies

Regional Brain Institute

Regional Brain Institute is a physician owned practice group that provides intensely patient focused care in affiliation with regional, metropolitan, rural, and Indian Nation healthcare organizations.

BrightSpace Senior Living

BrightSpace Senior Living is a retirement company that focuses on Assisted Living and Independent Living. They provide wellness programs, outstanding services, and a full calendar of events catered to seniors to promote an active, carefree lifestyle.

Fruit Street

Fruit Street delivers the CDC`s Diabetes Prevention Program using telehealth, wearable devices, and mobile applications. The diabetes prevention program is a 1-year long diet and lifestyle intervention designed to help pre-diabetic patients lose 5-7% of their weight through diet and lifestyle changes. The program is based on clinical research that was published in the New England Journal of Medicine in 2002 which showed that patients who complete the program have a 58% risk reduction for developing diabetes.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.

Sawtooth Labs

Sawtooth Labs is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.